Search PubMed⌕ Search

SEARCH · Search PubMed

Results for “Tranexamic Acid”

Search indexed PubMed citations on genomics, clinical trials, systematic reviews and public health. Explore titles, authors and supplied subject terms, then open the PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 1,477 records · Page 82Linked to original sources

[General anesthesia components during abdominal surgeries in patients with abdominal sepsis].

Results of optimization of general anesthesia during abdominal surgeries in patients with abdominal sepsis are analyzed. Inhibitors of proteases (transamin and antagozan) were used as non-opiate component in transduction stage. Central hemodynamics, gaseous metabolism and heart rate were analyzed in two groups of patients: group 1 -- anesthesia was carried out with inhibitors of proteases (32 patients), group 2 -- without it (30 patients). High efficacy of the inhibitors was demonstrated. Inhibitors of proteases are indicated for anesthesia in patients with severe metabolic disorders associated with tissues hypoxia. Analgesic activity of transamin permits one to decrease doses of anesthetic medication with a cardiodepressive effect.

Abdomen↗

Pregnancy in a patient of Glanzmann's thrombasthenia.

Glanzmann's thrombasthenia is a congenitally acquired platelet disorder with an autosomal recessive mode of inheritance. Though, quantitatively normal, the aggregation ability of platelets is reduced in this condition. Pregnancy and delivery are rare in these patients and have been associated with a high risk of severe post-partum hemorrhage. We describe a primigravida, who was diagnosed to have Glanzmann's thrombasthenia during adolescence. She developed secondary post-partum hemorrhage after an elective caesarean section, which was successfully managed by single donor platelet transfusion.

Adult↗

Menorrhagia.

Explore the source record for details and available documents.

Anti-Inflammatory Agents, Non-Steroidal↗

[Hereditary angioedema. Description of a pediatric case].

Hereditary angioedema is a disease due to deficiency or functional anomaly of the serum inhibitor of C1-esterase, clinically characterised by the recurrence of oedematous episodes in the subcutis and mucosas; if not diagnoses in time, this condition is potentially fatal (up to 50% of cases for edema of the glottis). A case diagnosed in paediatric age is reported.

Angioedema↗

[Studies on fibrinolysis and ascites accumulation associated with peritonitis carcinomatosa--effects of protease inhibitors (PI) on MM2 ascites tumor growth, ascites accumulation and fibrinolysis].

The effects of protease inhibitors(PI), t-AMCHA, gabexate, aprotinin and heparin on the growth of mouse MM2 ascites tumor (MAT) and on several components of fibrinolysis were studied. The drugs were administered intraperitoneally one time daily for 12 days, one day after the tumor transplant. The volumes of ascites, total packed cell volume (TPCV) and fibrinolytic parameters (FDP, whole plasmin, plasminogen activator (PA)) were measured on the 8, 10 and 12th days of therapy. Fibrinolytic activity was assayed by the lysin sepharose affinity chromatography-radio caseinolytic method. Fibrinolytic activity in the ascites increased during the tumor growth. The ascites accumulation as well as levels of FDP, whole plasmin and PA in the drug treated group were significantly decreased when compared to the control group. In these drug-treated groups, MAT cells agglutinated in the abdominal cavity, but in contrast to this, no agglutination was observed in the control group. It was uncertain whether PI directly inhibited tumor growth. The fact that PI inhibited the ascites accumulation and also decreased fibrinolytic activity suggest the involvement of protease in the neoplastic process and indicates another therapeutic approach to malignant ascites tumors.

Animals↗

[Hemorrhagic gastroduodenal ulcer: contribution of new medical treatments].

The mortality due to upper gastrointestinal haemorrhage from ulcers has remained unchanged for several (estimated to be 6%), despite progress in surgery and intensive care, new drug treatments and, more recently, the development of endoscopic treatments. Drug treatments, although frequently used in practice always have a controversial haemostatic efficacy. Antacids have a haemostatic efficacy, but only at doses responsible for side effects. Antisecretory drugs appear to be systematically prescribed, if only to commence treatment of the peptic ulcer disease. However, their haemostatic efficacy has not been established except in the sub-group of gastric ulcers, especially in elderly subjects. According to a recent study, prostaglandins are as active as antacids. Since 1975, endoscopy is the support for haemostatic treatments, most of which are still under evaluation. Therapeutic injections, a simple and inexpensive technique, certainly represents one of the most promising methods. Different authors have proposed different solutions for injection (absolute alcohol, aetoxysclerol, adrenaline, thrombin...) with comparable haemostatic efficacy. Laser photocoagulation (Argon and Nd-YAG) is an expensive and impractical technique and a number of randomised studies indicate that the initial enthusiasm for this technique is not justified. Monopolar electrocoagulation does not constitute a real progress in contrast with bipolar electrocoagulation which significantly decreases the frequency of recurrent haemorrhages. Lastly, the efficacy of the heater probe remains to be evaluated in the light of promising studies, particularly those of Johnson in 1985. At the present time, these endoscopic haemostatic treatment should be reserved to high surgical risk patients (elderly or debilitated subjects).(ABSTRACT TRUNCATED AT 250 WORDS)

Antacids↗